RecruitingNot ApplicableNCT07014111

Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD


Sponsor

University of Illinois at Chicago

Enrollment

40 participants

Start Date

Sep 2, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Fight Fatigue is evaluating the feasibility and acceptability of a combined progressive muscle relaxation and walking intervention to reduce fatigue for adults with end-stage kidney disease receiving in-center hemodialysis.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Diagnosis of ESKD diagnosis and receiving hemodialysis for at least 3 months
  • Can read and speak English
  • Fatigue measured via visual analogue scale, score ≥4 over the last week
  • Able to stand and walk one block
  • Has a cell phone that can receive text messages

Exclusion Criteria6

  • Patient's nephrologist refuses for them to participate
  • Unstable angina
  • Unstable pulmonary disease or pulmonary symptoms that preclude participation
  • Lower-extremity amputation without prosthetic (BKA, AKA) -Orthopedic or neurologic condition that would preclude walking or tensing/releasing of muscles-
  • Cognitive impairment that, in the judgement of the research team, precludes trial participation
  • Participation in the formative phase of the development of Fight Fatigue

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALFight Fatigue

Combined progressive muscle relaxation and walking (increasing step count) 12-week intervention that consists of education/training followed by text messages.

OTHERAttention Control

End-stage kidney disease education


Locations(1)

UI Health/University of Illinois Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07014111


Related Trials